Giovanna Giuseppina Altobelli

Giovanna Giuseppina Altobelli

Advanced Biomedical Sciences, University of Naples Federico II, Naples, Campania, Italy
orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 November 2005 in Circulation Research
Verified
Journal Article
Closed access
Guido IaccarinoGuido Iaccarino
Guido Iaccarino
Michele CiccarelliMichele Ciccarelli
Michele Ciccarelli
DSDaniela Sorriento
Daniela Sorriento
Gennaro GalassoGennaro Galasso
Gennaro Galasso
ACAlfonso Campanile
Alfonso Campanile
BTBruno Trimarco
Bruno Trimarco
β2-Adrenergic receptors (β2ARs) are widely expressed, although their physiological relevance in many tissues is not yet fully understood. In vascular endothelial cells, they regulate NO release and vessel tone. Here we provide novel evidence that β2ARs can regulate neoangiogenesis in response to chronic ischemia. We used in vivo adenoviral-mediated gene transfer of the human β2AR to the endothelium of the rat femoral artery and increased β2AR signaling resulting in ameliorated angiographic blood flow and hindlimb perfusion after chronic ischemia. Histological analysis confirmed that β2AR overexpression also produced benefits on capillary density. The same maneuver partially rescued impaired angiogenesis in spontaneously hypertensive rats (SHR), whereas gene delivery of the G-protein–coupling defective mutant Ile164 β2AR failed to provide ameliorations. Stimulation of endogenous and overexpressed β2AR on endothelial cells in vitro was found to regulate cell number by inducing proliferation and [3H]-thymidine incorporation through means of extracellular receptor-activated kinase and vascular endothelial growth factor. The β2AR also has novel effects on endothelial cell number through stimulation of proapoptosis and antiapoptosis pathways involving p38 mitogen-activated protein kinase and PI3-kinase/Akt activation. Therefore, β2ARs play a critical role in endothelial cell proliferation and function including revascularization, suggesting a novel and physiologically relevant role in neoangiogenesis in response to ischemia.

8 June 2009 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
Gaetano SantulliGaetano Santulli
Gaetano Santulli
Michele CiccarelliMichele Ciccarelli
Michele Ciccarelli
GPGianluigi Palumbo
Gianluigi Palumbo
ACAlfonso Campanile
Alfonso Campanile
Gennaro GalassoGennaro Galasso
Gennaro Galasso
Guido IaccarinoGuido Iaccarino
Guido Iaccarino
The main regulator of neovascularization is Vascular Endothelial Growth Factor (VEGF). We recently demonstrated that QK, a de novo engineered VEGF mimicking peptide, shares in vitro the same biological properties of VEGF, inducing capillary formation and organization. On these grounds, the aim of this study is to evaluate in vivo the effects of this small peptide. Therefore, on Wistar Kyoto rats, we evaluated vasomotor responses to VEGF and QK in common carotid rings. Also, we assessed the effects of QK in three different models of angiogenesis: ischemic hindlimb, wound healing and Matrigel plugs. QK and VEGF present similar endothelium-dependent vasodilatation. Moreover, the ability of QK to induce neovascularization was confirmed us by digital angiographies, dyed beads dilution and histological analysis in the ischemic hindlimb as well as by histology in wounds and Matrigel plugs. Our findings show the proangiogenic properties of QK, suggesting that also in vivo this peptide resembles the full VEGF protein. These data open to new fields of investigation on the mechanisms of activation of VEGF receptors, offering clinical implications for treatment of pathophysiological conditions such as chronic ischemia.

18 December 2007 in Cardiovascular Research
Verified
Journal Article
Open access
PDF file
DLDario Leosco
Dario Leosco
Giuseppe RengoGiuseppe Rengo
Giuseppe Rengo
Guido IaccarinoGuido Iaccarino
Guido Iaccarino
LGLuca Golino
Luca Golino
MMMassimo Marchese
Massimo Marchese
FRFranco Rengo
Franco Rengo
We investigated whether exercise training could promote angiogenesis and improve blood perfusion and left ventricular (LV) remodelling of the post-myocardial infarction (MI) failing heart. We also explored the contribution of ameliorated β-adrenergic receptor signalling and function on the overall improvement of cardiac contractility reserve induced by exercise. Adult Wistar male rats were randomly assigned to one of four experimental groups. Sham-operated and post-MI heart failure (HF) rats were housed under sedentary conditions or assigned to 10-weeks of a treadmill exercise protocol. At 4 weeks after MI, sedentary HF rats showed LV eccentric hypertrophy, marked increase of LV diameters associated with severely impaired fractional shortening (14 ± 5%), increased LV end diastolic pressure (20.9 ± 2.6 mmHg), and pulmonary congestion. In addition, cardiac contractile responses to adrenergic stimulation were significantly blunted. In trained HF rats, exercise was able to (i) reactivate the cardiac vascular endothelial growth factor pathway with a concurrent enhancement of myocardial angiogenesis, (ii) significantly increase myocardial perfusion and coronary reserve, (iii) reduce cardiac diameters, and (iv) improve LV contractility in response to adrenergic stimulation. This latter finding was also associated with a significant improvement of cardiac β-adrenergic receptor downregulation and desensitization. Our data indicate that exercise favourably affects angiogenesis and improves LV remodelling and contractility reserve in a rat model of severe chronic HF.

18 November 2008 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
DSDaniela Sorriento
Daniela Sorriento
Michele CiccarelliMichele Ciccarelli
Michele Ciccarelli
Gaetano SantulliGaetano Santulli
Gaetano Santulli
ACAlfonso Campanile
Alfonso Campanile
GAGiovanna Giuseppina Altobelli
Giovanna Giuseppina Altobelli
Guido IaccarinoGuido Iaccarino
Guido Iaccarino
G-protein-coupled receptor (GPCR) kinases, GRKs, are known as serine/threonine kinases that regulate GPCR signaling, but recent findings propose functions for these kinases besides receptor desensitization. Indeed, GRK5 can translocate to the nucleus by means of a nuclear localization sequence, suggesting that this kinase regulates transcription events in the nucleus. To evaluate the effect of GRK5–IκBα interaction on NFκB signaling, we induced the overexpression and the knockdown of GRK5 in cell cultures. GRK5 overexpression causes nuclear accumulation of IκBα, leading to the inhibition of NFκB transcriptional activity. Opposite results are achieved by GRK5 knockdown through siRNA. A physical interaction between GRK5 and IκBα, rather than phosphorylative events, appears as the underlying mechanism. We identify the regulator of gene protein signaling homology domain of GRK5 (RH) and the N-terminal domain of IκBα as the regions involved in such interaction. To confirm the biological relevance of this mechanism of regulation for NFκB, we evaluated the effects of GRK5-RH on NFκB-dependent phenotypes. In particular, GRK5-RH overexpression impairs apoptosis protection and cytokine production in vitro and inflammation and tissue regeneration in vivo. Our results reveal an unexpected role for GRK5 in the regulation of NFκB transcription activity. Placing these findings in perspective, this mechanism may represent a therapeutic target for all those conditions involving excessive NFκB activity.

12 May 2020 in Frontiers in Medicine
Verified
Journal Article
Open access
PDF file
GAGiovanna Giuseppina Altobelli
Giovanna Giuseppina Altobelli
SNSusan Van Noorden
Susan Van Noorden
ABAnna Balato
Anna Balato
VCVincenzo Cimini
Vincenzo Cimini
Superoxide dismutase is widespread in the human body, including skin and its appendages. Here, we focus on human skin copper/zinc superoxide dismutase, the enzyme that protects skin and its appendages against reactive oxygen species. Human skin copper/zinc superoxide dismutase resides in the cytoplasm of keratinocytes, where up to 90% of cellular reactive oxygen species is produced. Factors other than cell type, such as gender, age and diseased state influence its location in skin tissues. We review current knowledge of skin copper/zinc superoxide dismutase including recent studies in an attempt to contribute to solving the question of its remaining unexplained functions. The research described here may be applicable to pathologies associated with oxidative stress. However, recent studies on copper/zinc superoxide dismutase in yeast reveal that its predominant function may be in signaling pathways rather than in scavenging superoxide ions. If confirmed in the skin, novel approaches might be developed to unravel the enzyme's remaining mysteries.

1 March 2008 in British Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
Michele CiccarelliMichele Ciccarelli
Michele Ciccarelli
Gaetano SantulliGaetano Santulli
Gaetano Santulli
ACAlfonso Campanile
Alfonso Campanile
Gennaro GalassoGennaro Galasso
Gennaro Galasso
PCP Cervèro
P Cervèro
Guido IaccarinoGuido Iaccarino
Guido Iaccarino
Background and purpose: Intact endothelium plays a pivotal role in post‐ischaemic angiogenesis. It is a phenomenon finely tuned by activation and inhibition of several endothelial receptors. The presence of α1‐adrenoceptors on the endothelium suggests that these receptors may participate in regenerative phenomena by regulating the responses of endothelial cells involved in neo‐angiogenesis.Experimental approach: We evaluated the expression of the subtypes of the α1‐adrenoceptor in isolated endothelial cells harvested from Wistar‐Kyoto (WKY) rats. We explored the possibility these α1‐adrenoceptors may influence the pro‐angiogenic phenotype of endothelial cellsin vitro.In vivo, we used a model of hindlimb ischaemia in WKY rats, to assess the effects of α1adrenoceptor agonist or antagonist on angiogenesis in the ischaemic hindlimb by laser Doppler blood flow measurements, digital angiographies, hindlimb perfusion with dyed beads and histological evaluation.Key results: In vitro, pharmacological antagonism of α1‐adrenoceptors in endothelial cells from WKY rats by doxazosin enhanced, while stimulation of these adrenoceptors with phenylephrine, inhibited endothelial cell proliferation and DNA synthesis, ERK and retinoblastoma protein (Rb) phosphorylation, cell migration and tubule formation.In vivo, we found increased α1‐adrenoceptor density in the ischaemic hindlimb, compared to non‐ischaemic hindlimb, suggesting an enhanced α1‐adrenoceptor tone in the ischaemic tissue. Treatment with doxazosin (0.06 mg kg−1 day−1for 14 days) did not alter systemic blood pressure but enhanced neo‐angiogenesis in the ischaemic hindlimb, as measured by all our assays.Conclusions: Our findings support the hypothesis that the α1‐adrenoceptors in endothelial cells provide a negative regulation of angiogenesis.British Journal of Pharmacology(2008)153, 936–946; doi:10.1038/sj.bjp.0707637; published online 17 December 2007